The relevant comparison depended on whether patients were concurrently receiving opioids.
What the supplied research shows
A retrospective Medicare cohort included 400,924 adults aged sixty-five or older starting benzodiazepine hypnotics, Z-drugs or low-dose trazodone. Without concurrent opioids, adjusted mortality comparisons did not clearly differ from trazodone. During concurrent opioid use, benzodiazepine hypnotics were associated with higher out-of-hospital and total mortality, with adjusted hazard ratios of 3.02 and 2.21 respectively. The association persisted when overdose deaths were excluded.
What it cannot establish
This was not random assignment, and residual differences between treatment groups could remain. The selected cohort excluded severe illness and evidence of substance use disorder. The absence of a significant difference without opioids does not establish that the drugs were harmless or interchangeable for every outcome.
Forensic interpretation and case review
For a death investigation, identify the actual overlap in use rather than list prescriptions without dates. Mortality associations do not establish a fatal concentration, a precise interaction magnitude in one person, or the cause of an individual death. Consider respiratory disease, cardiac disease, competing causes and the reliability of administration records. The study demonstrates why co-exposure belongs in the analysis while leaving individual causation dependent on the full clinical and toxicological record.
Source and related reading
Source: supplied full-text paper, PMC8321368. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.
Related: Benzodiazepine Associations in an Overdose Survey Depended on the Time Window Studied.
Leave a Reply